tiprankstipranks
Trending News
More News >
NRX Pharmaceuticals (DE:B1Q)
FRANKFURT:B1Q
Germany Market

NRX Pharmaceuticals (B1Q) Ownership - Who Owns NRX Pharmaceuticals?

Compare
1 Followers

NRX Pharmaceuticals (B1Q) Ownership Overview

7.78%2.39%7.59%3.60%78.65%
2.39%
Mutual Funds
7.59% Other Institutional Investors
3.60% ETFs
78.65% Public Companies and Individual Investors
The ownership structure of NRX Pharmaceuticals (DE:B1Q) stock is a mix of institutional, retail, and individual investors. Approximately 13.57% of the company’s stock is owned by Institutional Investors, 7.78% is owned by Insiders, and 78.65% is owned by Public Companies and Individual Investors.
The ownership structure of NRX Pharmaceuticals (DE:B1Q) stock is a mix of institutional, retail, and individual investors. Approximately 9.98% of the company’s stock is owned by Institutional Investors, 7.78% is owned by Insiders, and 3.60% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Dec 18, 2024
xxxxxxxxxxxxx
$46800

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
1,516,834Insider7.78%4,832,633
437,640Institution2.24%1,394,321
388,925Institution1.99%1,239,115
263,797Institution1.35%840,457
71,798Institution0.37%228,748
4,473Institution0.02%14,251
50Institution<0.01%159

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
388,925Institution1.99%1,239,115
71,798Institution0.37%228,748
4,473Institution0.02%14,251

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns NRX Pharmaceuticals (DE:B1Q)?
According to the latest TipRanks data, approximately 7.59% of the company's stock is held by institutional investors, 7.78% is held by insiders, and 78.65% is held by retail investors.
    What percentage of NRX Pharmaceuticals (DE:B1Q) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 7.59% of NRX Pharmaceuticals (DE:B1Q) stock is held by institutional investors.
      What percentage of NRX Pharmaceuticals (DE:B1Q) stock is held by retail investors?
      According to the latest TipRanks data, approximately 78.65% of NRX Pharmaceuticals (DE:B1Q) stock is held by retail investors.
        Who owns the most shares of NRX Pharmaceuticals (DE:B1Q)?
        Jonathan Javitt owns the most shares of NRX Pharmaceuticals (DE:B1Q).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis